Clearance and Half-Life

Clearance and half-life are the two parameters that summarize how the body removes a drug. Clearance measures the efficiency of removal — the volume of plasma cleared of drug per unit time — while half-life measures the time course — how long it takes the concentration to fall by half. They are linked through the volume of distribution, and confusing the two is a common source of error.

Definition

Clearance is the volume of plasma irreversibly cleared of drug per unit time; elimination half-life is the time required for the plasma concentration to decrease by one half during the elimination phase, determined jointly by clearance and the volume of distribution.

Scope

This entry defines clearance, elimination half-life, and the rate constant of elimination, explains how they relate to the volume of distribution, and describes how half-life governs accumulation and the approach to steady state. It treats these as pharmacokinetic parameters for reference; it gives no dosing regimens.

Core questions

• How are clearance, volume of distribution, and half-life mathematically related?
• Why is clearance, not half-life, the primary determinant of steady-state exposure?
• How many half-lives are needed to approach steady state or to wash a drug out?
• How can two drugs share a half-life yet differ greatly in clearance?

Key concepts

• Clearance
• Elimination half-life
• Elimination rate constant
• Volume of distribution
• First-order elimination
• Steady state and accumulation
• Area under the curve

Mechanisms

Under first-order elimination, the rate at which a drug leaves the body is proportional to its plasma concentration, and clearance is the proportionality constant — the volume of plasma fully cleared per unit time, summed across all eliminating organs. Half-life is not an independent property: it is set by the ratio of the volume of distribution to clearance, so a drug can have a long half-life either because it is removed slowly (low clearance) or because it is widely distributed (large volume). Because the fall is exponential, roughly half the drug is gone after one half-life and the great majority after about four to five; the same arithmetic governs how quickly a constant-rate input reaches steady state. Average steady-state exposure, by contrast, depends on dosing rate and clearance, not on half-life.

Clinical relevance

These parameters explain why half-life predicts how long a drug lingers and how often it must be given to maintain exposure, while clearance predicts the exposure that a given input will produce. The topic underpins interpretation of pharmacokinetic studies and dosing-interval reasoning at a conceptual level; it describes parameters for reference and is not individualized dosing advice.

Evidence & guidelines

Clearance and half-life are foundational pharmacokinetic constructs codified in standard texts such as Rowland and Tozer and Gibaldi and Perrier, which derive their relationships to the volume of distribution and steady state. The physiological interpretation of clearance as an organ-level property is grounded in the analyses of Wilkinson and Shand, and the scaling of these parameters across species is discussed by Boxenbaum.

History

The compartmental description of drug disposition was systematized in mid-twentieth-century pharmacokinetics and consolidated in the textbooks of Gibaldi and Perrier. The reframing of clearance as a physiological, organ-based quantity in the 1970s clarified that half-life is a derived rather than fundamental parameter, a distinction that has shaped pharmacokinetic teaching ever since.

Key figures

• Malcolm Rowland
• Thomas Tozer
• Milo Gibaldi
• Grant Wilkinson

Seminal works

• wilkinson-shand-1975
• gibaldi-perrier-1982
• rowland-tozer-2011

Frequently asked questions

Is half-life or clearance the better measure of how the body removes a drug?

Clearance is the more fundamental measure of removal efficiency; half-life is a derived parameter that also depends on the volume of distribution, so two drugs with the same clearance can have different half-lives.

How many half-lives does it take to reach steady state?

With constant dosing, a drug reaches roughly 90 percent of its steady-state concentration after about three to four half-lives and is essentially at steady state after about five.